维普中文期刊产品整合服务
20篇 您的检索式:作者名="Liebisch P"
    题名 作者 年代 出处 被引量
1Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma显示文摘KAISER M MIETH M LIEBISCH P 2008Eur J Haematol2008,80,6:1
2Velcade,intravenous cyclophosphamide and dexamethasone induction for previously untreated multiple myeloma (German DSMM Xia trial)显示文摘Einsele H Liebisch P Langer C 2009{H}Blood2009,,22:1
3Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma显示文摘Kaiser M Mieth M Liebisch P 2008Eur J Haematol2008,80,6:1
4Serum con-centrations of DKK-1 correlate with the extent ofbone disease in patients with multiple myeloma显示文摘Kaiser M Mieth M Liebisch P 2008Eur J Haematol2008,80,6:1
5Light-chain escape-multiple myeloma-an escape phenomenon from plateau phase:report of the largest patient series using LC-monitoring显示文摘KUHNEMUND A LIEBISCH P BAUCHMULLER K 2009J Cancer Res Clin Oncol2009,135,:1
6' Light - chain escape - multiple myeloma' - an escape phenomenon from plateau phase: report of the largest patient series using LC - monitoring 显示文摘Ktihnemund A Liebisch P Bauchmtiller K 2009J Cancer Res Clin Oncol2009,135,3:1
7Diagnostic utility of the B-cell lineage markers CD20,CD79α,PAX5,and CD19 in paraffin-embedded tissues from lymphoid neoplasms显示文摘Adams H Liebisch P Schmid P 2009Appl Immunohistochem Mol Morphol2009,17,:1
8Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma显示文摘Jakob C Egerer K Liebisch P 2007Blood2007,109,5:1
9The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity显示文摘Dorsch S Liebisch G Kaufmann B von Landenberg P 2002J Virol2002,76,:1
10CD44v6,a target fornovel antibody treatment approaches,is frequently expressed inmultiple myeloma and associated with deletion of chromosome arm13q显示文摘Liebisch P Eppinger S Schpflin C 2005Haematologica2005,90,4:1
11Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)显示文摘Knop S Gerecke C Liebisch P 2009Blood2009,113,:1
12Bortezomib in combination with high-dose dexamethasome and continuous low-dose oral cyclophosphamide for relapsed muhiple myeloma 显示文摘Kropff M Bisping G Liebisch P 2005Blood2005,106,:1
13Duplication of chromosome arms 9q and 11q:evidence for a novel,14q32Translocation independent pathogenetic pathway in multiple myeloma显示文摘Liebisch P Scheck D Erne S A 2005Genes Chromosomes Cancer2005,42,1:1
14Lenalidomide,adriamycin,anddexamethasone (RAD) in patients with relapsed and refractory multiple myeloma:a report from the German Myeloma Study GroupDSMM (Deutsche Studiengruppe Multiples Myelom)显示文摘Knop S Gerecke C Liebisch P 2009Blood2009,113,18:1
15CD44v6,a target for novel antibody treatment approaches,is frenquently expressed in multiple myeloma and associated with deletion of chromosome arm 13q显示文摘Liebisch P Eppinger S Schopflin C 2005Haematologica2005,90,4:1
16Serum concentrations of DKK-I correlate with the extent of bone disease in patients with multiple myeloma显示文摘Kaiser M Mieth M Liebisch P 2008Eur J Haematol2008,80,6:1
17Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma显示文摘Kaiser M Miet M Liebisch P 2008Eur J Haematol2008,80,6:1
18Cytogenetics and molecular cytogenetics in multiple myeloma显示文摘LIEBISCH P DOEHNER H 2006Eur J Cancer2006,42,:1
19High incidence of trisomies lq, 9q, and llq in multiple myeloma: results from a comprehensive molecular cytogenetic analysis 显示文摘Liebisch P Wendl C Wellmann A 2003Leukemia2003,17,12:1
20Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma显示文摘KAISER M MIETH M LIEBISCH P 2008Eur J Haematol2008,80,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费